Bristol Myers to sell 60% stake in China-US joint venturenews2025-09-15T20:00:53+00:00September 15th, 2025|Endpoints News|
RFK Jr. adds five new ACIP panelists ahead of key meetingnews2025-09-15T19:46:29+00:00September 15th, 2025|Endpoints News|
AbbVie loses appeal over Mississippi 340B state lawnews2025-09-15T19:00:34+00:00September 15th, 2025|Endpoints News|
Pharma mulls UK divestments as government action lags in life sciencesnews2025-09-15T17:48:49+00:00September 15th, 2025|Endpoints News|
Updated: Novartis extends deal spree with $120M for Monte Rosa’s immune degradersnews2025-09-15T11:29:56+00:00September 15th, 2025|Endpoints News|
AstraZeneca halts another UK investment, following Merck and Lilly movesnews2025-09-12T19:37:36+00:00September 12th, 2025|Endpoints News|
Top drug regulator pushes back on report that FDA wants to ‘abandon’ some adcommsnews2025-09-12T18:22:06+00:00September 12th, 2025|Endpoints News|
Lilly loses bid to overturn $183.7M judgment in Medicaid rebate fightnews2025-09-12T15:59:58+00:00September 12th, 2025|Endpoints News|
Lilly’s UK Gateway Labs plans uncertain in new blow to region’s biopharma industrynews2025-09-12T15:19:34+00:00September 12th, 2025|Endpoints News|
KalVista reports strong sales in early launch of hereditary angioedema drugnews2025-09-12T11:14:43+00:00September 12th, 2025|Endpoints News|
